Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model
Top Cited Papers
- 19 July 2004
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (30) , 11159-11164
- https://doi.org/10.1073/pnas.0402026101
Abstract
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by selective loss of motor neurons and progressive muscle wasting. Growing evidence indicates that mitochondrial dysfunction, not only occurring in motor neurons but also in skeletal muscle, may play a crucial role in the pathogenesis. In this regard, the life expectancy of the ALS G93A mouse line is extended by creatine, an intracellular energy shuttle that ameliorates muscle function. Moreover, a population of patients with sporadic ALS exhibits a generalized hypermetabolic state of as yet unknown origin. Altogether, these findings led us to explore whether alterations in energy homeostasis may contribute to the disease process. Here, we show important variations in a number of metabolic indicators in transgenic ALS mice, which in all shows a metabolic deficit. These alterations were accompanied early in the asymptomatic phase of the disease by reduced adipose tissue accumulation, increased energy expenditure, and concomitant skeletal muscle hypermetabolism. Compensating this energetic imbalance with a highly energetic diet extended mean survival by 20%. In conclusion, we suggest that hypermetabolism, mainly of muscular origin, may represent by itself an additional driven force involved in increasing motor neuron vulnerability.Keywords
This publication has 39 references indexed in Scilit:
- Up‐regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosisThe FASEB Journal, 2003
- A randomized sequential trial of creatine in amyotrophic lateral sclerosisAnnals of Neurology, 2003
- Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disordersCurrent Opinion in Clinical Nutrition and Metabolic Care, 2002
- Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic MiceJournal of Biological Chemistry, 2002
- Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosisBrain, 2000
- Resting Energy Expenditure is Sensitive to Small Dose Changes in Patients on Chronic Thyroid Hormone ReplacementJournal of Clinical Endocrinology & Metabolism, 1997
- Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosisAnnals of Neurology, 1996
- An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondriaNeuron, 1995
- Positional cloning of the mouse obese gene and its human homologueNature, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993